Amylyx May Pull FDA-Approved ALS Drug Amylyx May Pull FDA-Approved ALS Drug

Topline results for the ALS drug Relyvrio show that it failed to meet primary or secondary endpoints. The company says it may voluntarily pull the drug from the market.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery Source Type: news